Retired Cholesterol Drug Shows Promise for Alzheimer's Prevention in Small Trial
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
20 articles
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Mayo Clinic study reveals how early estrogen treatment affects brain blood flow and cognitive aging in postmenopausal women.
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
A completed trial tests EGCG combined with diet, exercise, and cognitive training to slow decline in ApoE4 carriers with early warning signs.
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
A completed pilot trial tests whether 2g/day of a novel carnosine formulation can restore neuromuscular function and quality of life in MS patients.
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
Personalized treatment approach targeting multiple causes of cognitive decline outperformed standard care in 9-month trial.
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
Completed study of 102 older adults tested whether combined interventions can preserve brain volume and improve mobility through muscle-brain axis.
A completed RCT tests whether 6 months of moderate aerobic exercise protects memory and brain structure in older adults at genetic risk for Alzheimer's.
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
Novel movement program combining Eastern and Western exercises may help maintain independence and cognitive function in dementia patients.
Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.
12-week study reveals how aerobic and strength training improve cognitive performance by altering stress hormones and brain proteins.
180-person study explores whether Mediterranean eating patterns can prevent cognitive decline in overweight seniors.
Italian researchers developed a biosensor to track extracellular vesicles in blood, potentially personalizing stroke rehabilitation.
Major study reveals sleep breathing disorders may accelerate brain aging and memory decline, even before cognitive symptoms appear.
A Phase 2 trial explores whether cilostazol, a blood thinner with brain-protective effects, can slow memory loss in MCI patients.